Rigel Pharmaceuticals reported $7.12M in Stock for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Amgen AMGN:US USD 4.76B 203M
Anika Therapeutics ANIK:US USD 37.24M 1.9M
Biomarin Pharmaceutical BMRN:US USD 839.46M 37.14M
Bristol Myers Squibb BMY:US USD 2.07B 68M
Daiichi Sankyo 4568:JP JPY 262.13B 12.82B
Eli Lilly And LLY:US USD 3.83B 68.3M
Halozyme Therapeutics HALO:US USD 103.28M 5.66M
Heron Therapeutics HRTX:US USD 52.24M 9.08M
Intrexon XON:US USD 219K 5K
Karyopharm Therapeutics KPTI:US USD 4.25M 779K
Ligand Pharmaceuticals LGND:US USD 22.33M 2.45M
Macrogenics MGNX:US USD 1.09M 1.86M
Neurocrine Biosciences NBIX:US USD 37M 7.7M
Regeneron Pharmaceuticals REGN:US USD 2.41B 193.7M
Rigel Pharmaceuticals RIGL:US USD 7.12M 898K
Ultragenyx Pharmaceutical RARE:US USD 21.85M 770K
Veracyte VCYT:US USD 13.8M 802K